VANCOUVER, BC, Aug. 5, 2021 /CNW/ - Kiaro Holdings Corp. (TSXV:
KO) ("Kiaro" or the "Company"), an omni-channel cannabis retailer
and distributor, is pleased to announce that the Company's
wholly-owned subsidiary, National Cannabis Distribution ("NCD"),
has entered into an Exclusive Reseller Agreement with RoyalMax
Biotechnology Canada Inc. d.b.a. West Island Culture ("West
Island"), to distribute Non-Medical Cannabis in Saskatchewan. West Island is a subsidiary of
Matica Enterprises Inc. (MMJ – CSE) (39N – Frankfurt) (MMJFF – OTC) ("Matica"). West
Island has delivered its first order to NCD for distribution to
their retail network.
"We are very pleased to be working with an organization such as
NCD. Matica is working to further expand our distribution
network and introduce more consumers to our brands of craft
cannabis," stated Matica CEO, Boris
Ziger. "Our premium OUESTTM and our
CITOYENTM brands have been well received in
Saskatchewan and elsewhere."
Brent McFadzen, General Manager
of NCD added, "NCD is excited to partner with Matica, as we prepare
to launch the RoyalMax portfolio within the Saskatchewan market and continue to provide
high quality cannabis products to our serviced retailers."
National Cannabis Distribution Inc.
National Cannabis Distribution Inc. (NCD) is a division of Kiaro
Holding Corp. (TSXV:KO) and is a leading wholesaler in the province
of Saskatchewan, the only
vertically integrated province in the Canadian cannabis market. NCD
claims over two-thirds of the market share in Saskatchewan and continues to build a solid
portfolio of products with a commitment to providing craft,
artisan, and boutique licensed producers a proven path to market
within Saskatchewan. With multiple
exclusive distribution partnerships in Saskatchewan and strategic feature planning,
NCD has positioned itself as a leader within the cannabis supply
community.
Kiaro Holdings Corp.
Based in Vancouver, British
Columbia, Kiaro is an independent, omni-channel cannabis
retailer and distributor. Through existing storefronts across
British Columbia, Saskatchewan and Ontario, a wholesale distribution division
servicing Saskatchewan, ecommerce
sites in Canada, the US and
Australia, and plans for continued
national expansion, Kiaro is driven to introduce new and
experienced consumers to a lifelong exploration of cannabis. With
more than 50 years of collective retail-focused experience, Kiaro's
leadership team has a proven track record of growing retail brands
across North America and plans to
open multiple retail locations nationwide over the coming
years.
Matica
Matica is a multi-faceted, innovative company in the Quebec cannabis space. Its subsidiary, West
Island Culture is a Dorval, Quebec
based Health Canada Licence Holder with standard cultivation
licence, standard processing, medical sales and sales licences.
MaAbout tica continues to work with Yunify Natural Technologies, a
Quebec based health and personal
care research and innovation company to develop proprietary
products for Matica and West Island, including topicals and ionic
mists. Through its acquisition of Trichome Treats, an award winning
chocolatier, Matica and West island intend on introducing edibles
into the West Island product mix. For more information on
Matica Enterprises please visit the website at:
www.maticaenterprises.com. For More information on our cannabis
brands please visit go-ouest.ca and citoyencannabis.ca
Forward-Looking Information
This news release contains statements that may constitute
"forward-looking information" within the meaning of applicable
Canadian securities legislation. Forward-looking information may
include, among others, statements regarding the future plans,
costs, objectives or performance of Kiaro, or the assumptions
underlying any of the foregoing. In this news release, words such
as "may", "would", "could", "will", "likely", "believe", "expect",
"anticipate", "intend", "plan", "estimate" and similar words and
the negative form thereof are used to identify forward-looking
statements. In this news release, forward-looking statements
relate, among other things, to: completion of the Transaction and
regulatory and other applicable approvals, proposed retail
expansion plans and management's ability to execute on same,
overall growth of the Canadian cannabis market and retail
opportunities, the integration and financial projections of
combined retail portfolio, the award of new operating permits and
licenses in various jurisdictions, and the timing and amount of any
dispositions of the Company's common shares. Forward-looking
statements should not be read as guarantees of future performance
or results, and will not necessarily be accurate indications of
whether, or the times at or by which, such future performance will
be achieved. No assurance can be given that any events anticipated
by the forward-looking information will transpire or occur.
Forward-looking information is based on information available at
the time and/or management's good-faith belief with respect to
future events and are subject to known or unknown risks,
uncertainties, assumptions and other unpredictable factors, many of
which are beyond Kiaro's control. These risks, uncertainties and
assumptions include, but are not limited to, those described in the
Kiaro Filing Statement dated September 29,
2020, a copy of which is available on SEDAR at
www.sedar.com, and could cause actual events or results to differ
materially from those projected in any forward-looking statements.
Furthermore, any forward looking information with respect to future
expansion plans is subject to the qualification that management of
Kiaro may decide, and the assumptions that any construction or
conversion would not be cost prohibitive, required permits will be
obtained and the labour, materials and equipment necessary to
complete such construction or conversion will be available.
Accordingly, readers should not place undue reliance on the
forward-looking statements and information contained in this news
release. Kiaro does not intend, nor undertake any obligation, to
update or revise any forward-looking information contained in this
news release to reflect subsequent information, events or
circumstances or otherwise, except if required by applicable
laws.
Neither TSX Venture Exchange nor its Regulation
Services Provider (as that term is defined in policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
For more information, visit: investors.kiaro.com
SOURCE Kiaro Holdings Corp.
